RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China Resources Sanjiu Medical & Pharmaceutical Co Stock

China Resources Sanjiu Medical & Pharmaceutical Co Equity 2024

China Resources Sanjiu Medical & Pharmaceutical Co Equity

18.97 B CNY

Ticker

000999.SZ

ISIN

CNE0000011K8

In 2024, China Resources Sanjiu Medical & Pharmaceutical Co's equity was 18.97 B CNY, a 11.51% increase from the 17.01 B CNY equity in the previous year.

China Resources Sanjiu Medical & Pharmaceutical Co Aktienanalyse

What does China Resources Sanjiu Medical & Pharmaceutical Co do?

China Resources Sanjiu Medical & Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing China Resources Sanjiu Medical & Pharmaceutical Co's Equity

China Resources Sanjiu Medical & Pharmaceutical Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding China Resources Sanjiu Medical & Pharmaceutical Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating China Resources Sanjiu Medical & Pharmaceutical Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

China Resources Sanjiu Medical & Pharmaceutical Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in China Resources Sanjiu Medical & Pharmaceutical Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about China Resources Sanjiu Medical & Pharmaceutical Co stock

What is the equity of China Resources Sanjiu Medical & Pharmaceutical Co this year?

China Resources Sanjiu Medical & Pharmaceutical Co has equity of 18.97 B CNY this year.

What was the equity of China Resources Sanjiu Medical & Pharmaceutical Co compared to the previous year?

The equity of China Resources Sanjiu Medical & Pharmaceutical Co has increased/decreased by 11.51% increased compared to the previous year.

What impact does a high equity have on investors of China Resources Sanjiu Medical & Pharmaceutical Co?

A high equity is advantageous for investors of China Resources Sanjiu Medical & Pharmaceutical Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of China Resources Sanjiu Medical & Pharmaceutical Co?

A low equity can be a risk for investors of China Resources Sanjiu Medical & Pharmaceutical Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of China Resources Sanjiu Medical & Pharmaceutical Co affect the company?

An increase in equity of China Resources Sanjiu Medical & Pharmaceutical Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of China Resources Sanjiu Medical & Pharmaceutical Co affect the company?

A reduction in equity of China Resources Sanjiu Medical & Pharmaceutical Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of China Resources Sanjiu Medical & Pharmaceutical Co?

Some factors that can affect the equity of China Resources Sanjiu Medical & Pharmaceutical Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of China Resources Sanjiu Medical & Pharmaceutical Co so important for investors?

The equity of China Resources Sanjiu Medical & Pharmaceutical Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can China Resources Sanjiu Medical & Pharmaceutical Co take to change the equity?

To change equity, China Resources Sanjiu Medical & Pharmaceutical Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does China Resources Sanjiu Medical & Pharmaceutical Co pay?

Over the past 12 months, China Resources Sanjiu Medical & Pharmaceutical Co paid a dividend of 1 CNY . This corresponds to a dividend yield of about 2.17 %. For the coming 12 months, China Resources Sanjiu Medical & Pharmaceutical Co is expected to pay a dividend of 1.09 CNY.

What is the dividend yield of China Resources Sanjiu Medical & Pharmaceutical Co?

The current dividend yield of China Resources Sanjiu Medical & Pharmaceutical Co is 2.17 %.

When does China Resources Sanjiu Medical & Pharmaceutical Co pay dividends?

China Resources Sanjiu Medical & Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of August, September, July, July.

How secure is the dividend of China Resources Sanjiu Medical & Pharmaceutical Co?

China Resources Sanjiu Medical & Pharmaceutical Co paid dividends every year for the past 18 years.

What is the dividend of China Resources Sanjiu Medical & Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 1.09 CNY are expected. This corresponds to a dividend yield of 2.37 %.

In which sector is China Resources Sanjiu Medical & Pharmaceutical Co located?

China Resources Sanjiu Medical & Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Resources Sanjiu Medical & Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Resources Sanjiu Medical & Pharmaceutical Co from 6/14/2024 amounting to 1.154 CNY, you needed to have the stock in your portfolio before the ex-date on 6/14/2024.

When did China Resources Sanjiu Medical & Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 6/14/2024.

What was the dividend of China Resources Sanjiu Medical & Pharmaceutical Co in the year 2023?

In the year 2023, China Resources Sanjiu Medical & Pharmaceutical Co distributed 0.853 CNY as dividends.

In which currency does China Resources Sanjiu Medical & Pharmaceutical Co pay out the dividend?

The dividends of China Resources Sanjiu Medical & Pharmaceutical Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Resources Sanjiu Medical & Pharmaceutical Co

Our stock analysis for China Resources Sanjiu Medical & Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Resources Sanjiu Medical & Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.